mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |